Nnan

vanbasten80 · 15-12-10, 17:51

0,0074$

+64%

NaturalNano, Inc. Moves to OTC Bulletin Board From Pink Sheets

vanbasten80 · 16-12-10, 14:37

news
NaturalNano Inc. Receives Additional Orders From Fiabila S.A. for Key Component of Nail Polish Products

dorotheum · 12-09-11, 15:51

chiedo una cortesia mi potreste postare il codice isin? grazie in anticipo

sevit · 13-09-11, 01:20

Citazione:

Originalmente inviato da dorotheum

chiedo una cortesia mi potreste postare il codice isin? grazie in anticipo

Ecco a Lei

ISIN: US63901A1051

dorotheum · 13-09-11, 01:27

Citazione:

Originalmente inviato da sevit

Ecco a Lei

ISIN: US63901A1051

grazie grazie grazie

che aria tira in usa?

sevit · 13-09-11, 02:05

Citazione:

Originalmente inviato da dorotheum

grazie grazie grazie

che aria tira in usa?

Sono in italia.... So a cosa. Ti riferisci :P

sevit · 13-09-11, 02:07

Citazione:

Originalmente inviato da sevit

Sono in italia.... So a cosa. Ti riferisci :P

Diciamo che sa*w non vuole partire anche se i volumi sono tornati a farsi sentire!

sostavietata · 14-09-11, 09:43

ImageShack® - Online Photo and Video Hosting

dorotheum · 11-10-11, 15:54

Enhanced Targeting of Cancer Cells for Capture Through the Use of NaturalNano's Halloysite Nanotubes Report to be Presented T...

Enhanced Targeting of Cancer Cells for Capture Through the Use of NaturalNano's Halloysite Nanotubes Report to be Presented T...
Data : 10/10/2011 @ 16:00
Fonte : GlobeNewswire Inc.

NaturalNano, Inc. (OTCBB:NNAN) (NaturalNano, Inc. - Home) announced today that Dr. Michael King's lab of Cornell University will present their recent work at The Biomedical Engineering Society Annual Meeting today (BMES | Meetings) at 11am.
The title of their presentation is "Halloysite Nanotube Coating Applications for Enhanced Capture and Reprogramming of Circulating Tumor Cells."

This presentation will demonstrate that the capture of circulating tumor cells (CTCs) in blood can be targeted more effectively by incorporation of NaturalNano's Halloysite Natural Tubes (HNT) onto the surface of devices used to capture circulating tumor cells (CTCs) in blood. King's Lab is developing new methods for the isolation of intact, viable cancer cells from patient blood based on the physiological adhesion of selectin proteins in micro-scale flow devices.

Dr. King, an Associate Professor of biomedical engineering at Cornell University, states, "The ability to create stable coatings of Halloysite nanotubes (HNT) using an extremely thin layer of poly-L-lysine allows the creation of nanostructured surfaces to which living cells respond. The microtubes with HNT incorporated onto their surface were found to enhance the natural CTC rolling mechanism. This allows the cells to be exposed to specific therapeutic agents or isolated and collected for diagnostic and research purposes."

James Wemett, NaturalNano CEO, said, "We are pleased to have our HNT technology used in Dr. King's important work. The use of HNT in a medical application is a new area of application for NNAN and we hope that Dr. King's work continues to advance. We were particularly pleased that HNT showed no harmful effect on the cells, enabling the capture of live cells ready for treatment or analysis."

About NaturalNano, Inc.

dorotheum · 11-10-11, 15:56

Correction: Enhanced Targeting of Cancer Cells for Capture Through the Use of NaturalNano's Halloysite Nanotubes Report to be...

Correction: Enhanced Targeting of Cancer Cells for Capture Through the Use of NaturalNano's Halloysite Nanotubes Report to be...
Data : 11/10/2011 @ 14:00

NaturalNano, Inc. (OTCBB:NNAN) (NaturalNano, Inc. - Home) is sorry for the confusion caused by yesterday's release. Dr. Michael King's lab of Cornell University will present their recent work at The Biomedical Engineering Society Annual Meeting (
The title of their presentation is "Halloysite Nanotube Coating Applications for Enhanced Capture and Reprogramming of Circulating Tumor Cells."

About NaturalNano, Inc.

NaturalNano, Inc. (OTCBB:NNAN) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including its proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and/or licenses 20 patents and applications relating to Halloysite, as well as proprietary know-how for its extraction and separation processes, compositions, and derivatives. NaturalNano, Inc. - Home.

15-12-10, 17:51	#1 (permalink)
vanbasten80 Member Data registrazione: Jul 2007 Messaggi: 650 Popolarità: 22715507	Nnan 0,0074$ +64% NaturalNano, Inc. Moves to OTC Bulletin Board From Pink Sheets

Strumenti discussione
Visualizza versione stampabile Invia questa pagina via e-mail
Modalità visualizzazione	Valuta questa discussione
Modalità lineare Passa a modalità ibrida Passa a modalità elenco	Valuta questa discussione:

16-12-10, 14:37	#2 (permalink)
vanbasten80 Member Data registrazione: Jul 2007 Messaggi: 650 Popolarità: 22715507	news NaturalNano Inc. Receives Additional Orders From Fiabila S.A. for Key Component of Nail Polish Products

12-09-11, 15:51	#3 (permalink)
dorotheum Member Data registrazione: Nov 2008 Messaggi: 3,697 Inserimenti nel blog: 1 Popolarità: 0	chiedo una cortesia mi potreste postare il codice isin? grazie in anticipo

14-09-11, 09:43	#8 (permalink)
sostavietata Member Data registrazione: Aug 2008 Messaggi: 2,019 Popolarità: 36433710	ImageShack® - Online Photo and Video Hosting

11-10-11, 15:54	#9 (permalink)
dorotheum Member Data registrazione: Nov 2008 Messaggi: 3,697 Inserimenti nel blog: 1 Popolarità: 0	Enhanced Targeting of Cancer Cells for Capture Through the Use of NaturalNano's Halloysite Nanotubes Report to be Presented T... Enhanced Targeting of Cancer Cells for Capture Through the Use of NaturalNano's Halloysite Nanotubes Report to be Presented T... Data : 10/10/2011 @ 16:00 Fonte : GlobeNewswire Inc. NaturalNano, Inc. (OTCBB:NNAN) (NaturalNano, Inc. - Home) announced today that Dr. Michael King's lab of Cornell University will present their recent work at The Biomedical Engineering Society Annual Meeting today (BMES \| Meetings) at 11am. The title of their presentation is "Halloysite Nanotube Coating Applications for Enhanced Capture and Reprogramming of Circulating Tumor Cells." This presentation will demonstrate that the capture of circulating tumor cells (CTCs) in blood can be targeted more effectively by incorporation of NaturalNano's Halloysite Natural Tubes (HNT) onto the surface of devices used to capture circulating tumor cells (CTCs) in blood. King's Lab is developing new methods for the isolation of intact, viable cancer cells from patient blood based on the physiological adhesion of selectin proteins in micro-scale flow devices. Dr. King, an Associate Professor of biomedical engineering at Cornell University, states, "The ability to create stable coatings of Halloysite nanotubes (HNT) using an extremely thin layer of poly-L-lysine allows the creation of nanostructured surfaces to which living cells respond. The microtubes with HNT incorporated onto their surface were found to enhance the natural CTC rolling mechanism. This allows the cells to be exposed to specific therapeutic agents or isolated and collected for diagnostic and research purposes." James Wemett, NaturalNano CEO, said, "We are pleased to have our HNT technology used in Dr. King's important work. The use of HNT in a medical application is a new area of application for NNAN and we hope that Dr. King's work continues to advance. We were particularly pleased that HNT showed no harmful effect on the cells, enabling the capture of live cells ready for treatment or analysis." About NaturalNano, Inc.

11-10-11, 15:56	#10 (permalink)
dorotheum Member Data registrazione: Nov 2008 Messaggi: 3,697 Inserimenti nel blog: 1 Popolarità: 0	Correction: Enhanced Targeting of Cancer Cells for Capture Through the Use of NaturalNano's Halloysite Nanotubes Report to be... Correction: Enhanced Targeting of Cancer Cells for Capture Through the Use of NaturalNano's Halloysite Nanotubes Report to be... Data : 11/10/2011 @ 14:00 NaturalNano, Inc. (OTCBB:NNAN) (NaturalNano, Inc. - Home) is sorry for the confusion caused by yesterday's release. Dr. Michael King's lab of Cornell University will present their recent work at The Biomedical Engineering Society Annual Meeting ( The title of their presentation is "Halloysite Nanotube Coating Applications for Enhanced Capture and Reprogramming of Circulating Tumor Cells." About NaturalNano, Inc. NaturalNano, Inc. (OTCBB:NNAN) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including its proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and/or licenses 20 patents and applications relating to Halloysite, as well as proprietary know-how for its extraction and separation processes, compositions, and derivatives. NaturalNano, Inc. - Home.

	Chi siamo- Pubblicità- Contatti- Disclaimer- Mappa- Credits
© 2000-2012 Browneditore S.p.A. - Tutti i diritti riservati. Prima di utilizzare anche parzialmente i contenuti di questo sito, vogliate cortesemente consultare il disclaimer.